Shanghai Henlius Biotech IPO Initiation: Going Large
Shanghai Henlius Biotech (1566213D HK) is a biopharmaceutical company and a non-wholly owned subsidiary of Shanghai Fosun Pharmaceutical (Group)...
891 Views
India Generic Drugs: US Antitrust Inquiry Widens
The US government's antitrust investigation of the generic drug industry has been quiet for more than a year and has resurfaced with a...
714 Views
Laurus Labs- Moving up the Value Addition Ladder
Laurus Labs (LAURUS IN) is a research and development driven pharmaceutical company. It is a manufacturer of APIs for ARV, Hepatitis C, oncology...
379 Views
Eris Lifesciences: Ask Some Questions, Take the Deal
Eris Lifesciences Limited (0113824Z IN) is an India-focused pharmaceutical company that produces and markets branded generic drugs. The company...
673 Views
Medrx - Japan Biotech Microcap in Potential Big Licensing Deal
Although the Japanese drug industry suffers from a lack of scale, where it is good is in applying manufacturing techniques to develop not just...
614 Views